Securities Fraud Investigation Into PennyMac Financial Services, Inc. (PFSI) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz — Neutral
PFSI Business Wire — February 02, 2026LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of PennyMac Financial Services, Inc. (“PennyMac” or the “Company”) (NYSE: PFSI) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON PENNYMAC FINANCIAL SERVICES, INC. (PFSI), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On January 29, 2026, PennyMac released.
Twist Bioscience: Ingenious Product Still Lacks Compelling Use Cases — Positive
TWST Seeking Alpha — February 02, 2026Twist Bioscience Corporation reported Q1 2026 revenue of $103.7M, up 17% YoY, and raised full-year guidance to $435–$440M. TWST targets adjusted EBITDA breakeven in Q4 2026, with gross margin expected above 52% for fiscal 2026. The company's DNA synthesis platform and AI-driven growth are promising, but profitability and market size remain concerns.
Wave Life Sciences Reclaims Rare Disease Drug From GSK, Targets Faster FDA Path — Positive
GSK WVE Benzinga — February 02, 2026On Monday, Wave Life Sciences Ltd. (NASDAQ: WVE) said it regained full rights to WVE-006 from GSK Plc (NYSE: GSK).
Coherent Q2 Earnings Preview: Buy Now or Wait for the Results? — Neutral
COHR Zacks Investment Research — February 02, 2026COHR moves ahead to post 2Q26 results, with revenue estimates of $1.6B, a rising EPS forecast and strong AI-driven demand aiding the company.
C&F Financial Q4 Earnings Rise Y/Y on Loan Growth, Margin Gains — Positive
CFFI Zacks Investment Research — February 02, 2026CFFI posts y/y earnings growth in 2025, driven by loan expansion, higher net interest margin and a solid performance across its banking segments.
Carpenter Technology Q2 Earnings Beat Estimates, Revenues Rise 8% Y/Y — Positive
CRS Zacks Investment Research — February 02, 2026CRS posts a Q2 earnings beat as a higher-margin mix and efficiency gains lift profits, even as revenues miss estimates.
Avery Dennison Stock to Report Q4 Earnings: Here's What to Expect — Negative
AVY Zacks Investment Research — February 02, 2026AVY is set to report Q4 earnings on Feb. 4, with expectations of revenue growth and margin pressure from higher costs.
Gold, Copper, and Missiles: 3 Big Dividend Raises After a Breakout Year — Positive
FNV LHX SCCO MarketBeat — February 02, 2026For the defense and mining industries, 2025 was a standout year. The iShares U.S. Aerospace & Defense ETF BATS: ITA tracks the performance of a basket of over 40 U.S. aerospace and defense companies.
ESAB Corporation (ESAB) M&A Call Transcript
UBS Group AG to Report Q4 Earnings: What's in Store for the Stock? — Neutral
UBS Zacks Investment Research — February 02, 2026UBS is set to report 4Q25 results on Feb. 4, with revenues expected to dip year over year, but earnings projected to rise.
Corpay Set to Report Q4 Earnings: Here's What Investors Should Know — Positive
CPAY Zacks Investment Research — February 02, 2026CPAY moves ahead to post fourth-quarter 2025 results, with revenues expected to rise 20% y/y, driven by strong growth across Vehicle and Corporate Payments.
Oracle Is Raising Billions to Fund Its AI Buildout. Today, Investors Are Cheering — Positive
ORCL Investopedia — February 02, 2026Oracle plans to raise billions to fund its ambitious bets on AI and cloud computing. That has the stock rising today.
Ralph Lauren Pre-Q3 Earnings: Is Brand Power Enough to Lift the Stock? — Positive
RL Zacks Investment Research — February 02, 2026RL's Q3 earnings trends indicate strong brand momentum and digital gains, but rising costs and tariffs loom ahead of the results.
Five Below Trades Above 50 & 200-Day SMAs: Time to Buy, Hold or Sell? — Positive
FIVE Zacks Investment Research — February 02, 2026FIVE trades above its 50 and 200-day SMAs as shares near highs, supported by strong momentum, store expansion and rising demand across price points.
Flagstar Financial Q4 Earnings Beat, NII Rises Y/Y, Expenses Fall — Positive
FLG Zacks Investment Research — February 02, 2026FLG beat Q4 earnings estimates as NII rises and credit costs plunge, but lower non-interest income and shrinking balances weigh on the results.
AI Capex Clouds The Tech Horizon, Even As Meta And Tesla Shine — Neutral
META TSLA Seeking Alpha — February 02, 2026With roughly a third of companies reporting thus far, S&P 500 EPS growth for Q4 2025 currently stands at 11.9%. This week, Alphabet, Amazon, and several consumer names take the stage as peak earnings season hits its stride. Potential earnings surprises this week: Disney, CME Group, Take-Two Interactive, Phillips 66 and more.
CRMT Investor News: If You Have Suffered Losses in America's Car-Mart, Inc. (NASDAQ: CRMT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights — Neutral
CRMT GlobeNewsWire — February 02, 2026NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of America's Car-Mart, Inc. (NASDAQ: CRMT) resulting from allegations that America's Car-Mart may have issued materially misleading business information to the investing public.
Fidelity National Financial: A Classic Case Of Outdated Market Fears — Neutral
FNF Seeking Alpha — February 02, 2026Fidelity National Financial trades at a 30% discount to intrinsic value, despite transforming into a diversified financial services platform. FNF's forward P/E of 8.7–10.4x and 4% dividend yield offer superior value and stability versus less diversified peers. The F&G Annuities & Life segment provides robust, counter-cyclical cash flow, mitigating housing market cyclicality and supporting stable returns.
FFIV DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages F5, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FFIV — Neutral
FFIV Newsfile Corp — February 02, 2026New York, New York--(Newsfile Corp. - February 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of F5, Inc. (NASDAQ: FFIV) between October 28, 2024 and October 27, 2025, both dates inclusive (the "Class Period"), of the important February 17, 2026 lead plaintiff deadline. SO WHAT: If you purchased F5 securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
